Product Reports Resources Pricing Login Book a demo

Aetion

Biotech & Life Sciences · New York City, United States · Founded 2012

Delivering real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers MoreLess

Aetion is a technology startup that operates in the healthcare sector, specifically in the area of real-world evidence (RWE). The company develops software solutions that help life sciences developers, regulators, and purchasers make critical decisions based on real-world data. Aetion's software provides insights into how medical innovations work in real-world settings, from initial hypothesis to long-term safety monitoring.

The company's clients include major players in the life sciences industry, such as pharmaceutical companies and healthcare regulators. Aetion's software allows these clients to generate and analyze a wide range of data, providing clinical insights that were previously unavailable. This data-driven approach helps expedite care and treatment options for patients in need.

Aetion's business model revolves around its software platform and complementary apps, which are designed to manage longitudinal data and generate synthetic health data using artificial intelligence (AI). The company also offers data, science, and regulatory services to help shape and speed up clients' real-world data strategies.

Aetion makes money by selling its software solutions and services to its clients. The company's value proposition is the ability to maximize return on investment on real-world data, by providing quick insights and facilitating critical decisions based on this data.

In conclusion, Aetion is a healthcare technology startup that leverages real-world data to help life sciences companies make informed decisions and expedite patient care.

Keywords: Healthcare Technology, Real-World Evidence, Life Sciences, Data Analysis, Software Solutions, Artificial Intelligence, Longitudinal Data Management, Regulatory Services, Synthetic Health Data, Patient Care.

Valuation $100–500M
Revenue $10–50M
Headcount <100
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Aetion and the history behind them.

Talent graph

Aetion's talent

Book a demo to see the people
Employees mapped 91 incl. 15 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on Aetion's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 12 investors entered at this stage
Flare Capital Partners
Lakestar
NEA
Amgen Ventures
Oxeon
McKesson Ventures
EDBI
Sanofi
Greenspring Associates
UCB Ventures
Johnson & Johnson Innovation
Horizon Blue Cross Blue Shield of New Jersey
Series B+ 4 investors entered at this stage

Global footprint

Where Aetion has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States63.1%
🇪🇸 Spain27.5%
🇫🇷 France2.7%
🇨🇦 Canada2.7%
🇵🇱 Poland1.3%
Top 5 of 9 shown
Web traffic by country
4.6K monthly visits
across markets
🇺🇸 United States82.6%
🇮🇳 India17.4%
Top 2 markets shown

Market sentiment

What the market is saying about Aetion

An AI-synthesized read of the highest-engagement posts about Aetion on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aetion on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.